Pharmaceutical

ESCMID 2024: Advances in drug resistance testing

Techniques such as rapid nanomotion-based susceptibility testing, and MALDI-TOF-MS could be used to identify resistance mechanisms of several deadly organisms.

May 5, 2024 - 00:00
ESCMID 2024: Advances in drug resistance testing
Techniques such as rapid nanomotion-based susceptibility testing, and MALDI-TOF-MS could be used to identify resistance mechanisms of several deadly organisms.
Read the original article

Tags:

Previous Article

Lexicon plans another bid for Zynquista in type 1 diabetes

Next Article

NHS to provide Pfizer’s Voxelotor to treat sickle cell disease

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: A junior scientist. A prominent oncologist. Now, a clash at MD Anderson over who gets research credit

STAT+: A junior scientist. A prominent oncologist. Now,...

Feb 9, 2024

Nestlé divests peanut allergy treatment Palforzia to Stallergenes Greer

Nestlé divests peanut allergy treatment Palforzia to St...

Sep 5, 2023

DB-1310 by Duality Biologics (Shanghai) for Non-Small C...

Dec 6, 2023